Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elbein, S. C.
Right arrow Articles by Kahn, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elbein, S. C.
Right arrow Articles by Kahn, S. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 23, Issue 2 221-227, Copyright © 2000 by American Diabetes Association


ARTICLES

Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds

SC Elbein, K Wegner and SE Kahn
Endocrinology Section, Central Arkansas Veterans Healthcare System, University of Arkansas for Medical Sciences, Little Rock, USA. elbeinstevenc@exchange.uams.edu

OBJECTIVE: Both obesity and a family history of diabetes reduce insulin sensitivity, but the impact of obesity on insulin secretion among individuals predisposed to diabetes is uncertain. We used a pedigree-based approach to test the hypothesis that beta-cell compensation to the insulin resistance associated with obesity is defective among individuals predisposed to diabetes by virtue of a strong family history of type 2 diabetes before the development of diabetes or glucose intolerance. RESEARCH DESIGN AND METHODS: A total of 126 members of 26 families ascertained for at least a sib pair with type 2 diabetes with onset before age 65 years underwent a tolbutamide-modified frequently sampled intravenous glucose tolerance test (FSIGT). Family members included 26 individuals with impaired glucose tolerance and 100 individuals with normal glucose tolerance (NGT). The acute insulin response to glucose (AIRglucose) was determined and insulin sensitivity (S(I)) estimated by minimal model analysis of FSIGT data. The beta-cell compensation for insulin sensitivity was estimated from the disposition index (DI), calculated as the product of S(I) and AIRglucose. Obesity was measured by BMI. RESULTS: Among all individuals, BMI was a significant predictor of both S(I) and AIRglucose, as expected. However, BMI also significantly predicted DI (P = 0.002) after correcting for age, sex, family membership, and glucose tolerance status. The relationship of BMI and DI was confirmed in 85 individuals with NGT who were aged <45 (P = 0.002) but not in 91 unrelated control individuals without a family history of diabetes. When normoglycemic individuals aged <45 were separated into three classes by BMI (< or =27, 27-30, >30), S(I) decreased progressively and significantly with obesity whereas AIRglucose rose significantly from lean to most obese classes. In contrast to the expectation of complete beta-cell compensation with obesity D1 fell significantly (P = 0.004) among obese family members. This relationship was not observed in control subjects. CONCLUSIONS: Individuals with a genetic predisposition to diabetes show a reduced beta-cell compensatory response to the reduced insulin sensitivity associated with obesity. We propose that this impaired compensation may be one manifestation of the underlying genetic defect in susceptible individuals. This finding helps explain the multiplicative effects of family history and obesity on risk of type 2 diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
N. Rasouli, H. J. Spencer, A. A. Rashidi, and S. C. Elbein
Impact of Family History of Diabetes and Ethnicity on -Cell Function in Obese, Glucose-Tolerant Individuals
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4656 - 4663.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. L. Wajchenberg
{beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment
Endocr. Rev., April 1, 2007; 28(2): 187 - 218.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
S.D.H. Malnick and H. Knobler
The medical complications of obesity
QJM, September 1, 2006; 99(9): 565 - 579.
[Full Text] [PDF]


Home page
Diabetes CareHome page
K. M. Utzschneider, R. L. Prigeon, D. B. Carr, R. L. Hull, J. Tong, J. B. Shofer, B. M. Retzlaff, R. H. Knopp, and S. E. Kahn
Impact of Differences in Fasting Glucose and Glucose Tolerance on the Hyperbolic Relationship Between Insulin Sensitivity and Insulin Responses
Diabetes Care, February 1, 2006; 29(2): 356 - 362.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Rasouli, T. Hale, S. E. Kahn, H. J. Spencer, and S. C. Elbein
Effects of Short-Term Experimental Insulin Resistance and Family History of Diabetes on Pancreatic {beta}-Cell Function in Nondiabetic Individuals
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5825 - 5833.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Teran-Garcia, T. Rankinen, R. A. Koza, D. C. Rao, and C. Bouchard
Endurance training-induced changes in insulin sensitivity and gene expression
Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1168 - E1178.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Wang, Z. Zhang, W. Chu, T. Hale, J. J. Cooper, and S. C. Elbein
Molecular Screening and Association Analyses of the Interleukin 6 Receptor Gene Variants with Type 2 Diabetes, Diabetic Nephropathy, and Insulin Sensitivity
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1123 - 1129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. B. Di Gregorio, R. Westergren, S. Enerback, T. Lu, and P. A. Kern
Expression of FOXC2 in adipose and muscle and its association with whole body insulin sensitivity
Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E799 - E803.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. C. Elbein and M. A. Karim
Does the Aspartic Acid to Asparagine Substitution at Position 76 in the Pancreas Duodenum Homeobox Gene (PDX1) Cause Late-Onset Type 2 Diabetes?
Diabetes Care, August 1, 2004; 27(8): 1968 - 1973.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Wang, H. Zhang, Y. Jia, Z. Zhang, R. Craig, X. Wang, and S. C. Elbein
Adiponectin Receptor 1 Gene (ADIPOR1) as a Candidate for Type 2 Diabetes and Insulin Resistance
Diabetes, August 1, 2004; 53(8): 2132 - 2136.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Zhang, Y. Jia, J. J. Cooper, T. Hale, Z. Zhang, and S. C. Elbein
Common Variants in Glutamine:Fructose-6-Phosphate Amidotransferase 2 (GFPT2) Gene Are Associated with Type 2 Diabetes, Diabetic Nephropathy, and Increased GFPT2 mRNA Levels
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 748 - 755.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Thamer, M. Stumvoll, A. Niess, O. Tschritter, M. Haap, R. Becker, F. Shirkavand, O. Bachmann, K. Rett, A. Volk, et al.
Reduced Skeletal Muscle Oxygen Uptake and Reduced {beta}-Cell Function: Two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes
Diabetes Care, July 1, 2003; 26(7): 2126 - 2132.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. B. Jensen, H. Storgaard, J. J. Holst, F. Dela, S. Madsbad, and A. A. Vaag
Insulin Secretion and Cellular Glucose Metabolism after Prolonged Low-Grade Intralipid Infusion in Young Men
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2775 - 2783.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. J. Mayer-Davis, G. J. Kirkner, A. J. Karter, and D. J. Zaccaro
Metabolic Predictors of 5-Year Change in Weight and Waist Circumference in a Triethnic Population: The Insulin Resistance Atherosclerosis Study
Am. J. Epidemiol., April 1, 2003; 157(7): 592 - 601.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Suzuki, M. Fukushima, M. Usami, M. Ikeda, A. Taniguchi, Y. Nakai, T. Matsuura, A. Kuroe, K. Yasuda, T. Kurose, et al.
Factors Responsible for Development From Normal Glucose Tolerance to Isolated Postchallenge Hyperglycemia
Diabetes Care, April 1, 2003; 26(4): 1211 - 1215.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Ahren and O. Thorsson
Increased Insulin Sensitivity Is Associated with Reduced Insulin and Glucagon Secretion and Increased Insulin Clearance in Man
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1264 - 1270.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. M. Clevenger, P. Parker Jones, H. Tanaka, D. R. Seals, and C. A. DeSouza
Decline in insulin action with age in endurance-trained humans
J Appl Physiol, December 1, 2002; 93(6): 2105 - 2111.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Wang, W. Chu, S. K. Das, Q. Ren, S. J. Hasstedt, and S. C. Elbein
Liver Pyruvate Kinase Polymorphisms Are Associated With Type 2 Diabetes in Northern European Caucasians
Diabetes, September 1, 2002; 51(9): 2861 - 2865.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Ando, T. Yatagai, K. Rokkaku, S. Nagasaka, S.-e Ishikawa, and S. Ishibashi
Obesity Is a Critical Risk Factor for Worsening of Glucose Tolerance in a Family With the Mutant Insulin Receptor
Diabetes Care, August 1, 2002; 25(8): 1484 - 1485.
[Full Text]


Home page
DiabetesHome page
J. B. Meigs, C. I. M. Panhuysen, R. H. Myers, P. W.F. Wilson, and L. A. Cupples
A Genome-Wide Scan for Loci Linked to Plasma Levels of Glucose and HbA1c in a Community-Based Sample of Caucasian Pedigrees: The Framingham Offspring Study
Diabetes, March 1, 2002; 51(3): 833 - 840.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. E. Kahn
The Importance of {beta}-Cell Failure in the Development and Progression of Type 2 Diabetes
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4047 - 4058.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.